Chief Pharmacist responsibilities with respect to radiopharmaceuticals have come more to the fore recently as a result of changes to the Ionising Radiation (Medical Exposure) Regulations (IR(ME)R) in 2017(1). The Chief Pharmacist is now required to play an active role in the process of applying for Employer licences under IR(ME)R, which are required in order to legally administer radiopharmaceuticals to patients.

Under the new arrangements, the application for the Employer Licence includes information on the facility, equipment, staff training and capacity for radiopharmaceutical provision. An individual doctor’s clinical suitability is assessed and approved under the Practitioner Licencing process.

Edition 3; Issued July 2020
Updated to incorporate changes to The Ionising Radiation (Medical Exposure) Regulations 2017.


Print this page